The Tumor Immunology Track at Roswell Park Comprehensive Cancer Center is focused on the increasingly complex interactions between tumors and the immune system and runs the complete gamut from basic mechanisms of immune responses, through translational development of novel therapies, to clinical trials. We offer a highly interactive, multidisciplinary course of study leading to a doctoral degree that prepares students for successful careers as independent investigators in cellular, molecular and tumor immunology.
As part of a world-class comprehensive cancer center we offer students the invaluable opportunity to become involved in translational research that brings investigator-initiated approaches for treating cancer into a clinical setting. We are the recipient of a unique NIH NCI sponsored pre-doctoral fellowship program in Translational Tumor Immunology, which provides funds for student stipends and travel and enhances the professional development of our students. Over the past several years, our students have:
- Published papers in high impact journals such as The Journal of Clinical Investigation, Nature Communications, The Proceedings of the National Academy of Sciences, Blood, Cancer Research and The Journal of Experimental Medicine
- Spoken about their research in front of international experts at prestigious national meetings such as the American Association of Immunology and the American Society of Hematology
- Received highly competitive pre-doctoral fellowships from the National Institutes of Health
Immunology graduates have gone on to careers in academia, industry and government. Recent graduates have accepted post-doctoral positions at institutions such as The Ohio State University, University of Texas Southwestern Medical Center, Harvard Medical School, Duke University, University of Pennsylvania and Indiana University.
“I found the ideal training environment in the Immunology PhD program at Roswell Park – challenging, collaborative and passionate. This environment made me confident in my expertise, which enabled me to present my work at numerous national and international meetings, as well as to collaborate with clinicians on clinical trials. As an Executive Branch AAAS Science & Technology Policy Fellow at the NIH, I will take this expertise and passion for tumor immunology with me to influence future policies to get novel immunotherapies to patients safely, quickly and cost-effectively.” – Kelly L. Singel, PhD, 2019
Dr. Kelly Singel, 2019 recipient of the Roswell Park Graduate Division Award for Excellence in Research
The application deadline for fall 2019 admission has passed. The next opportunity to apply for doctoral study at the Roswell Park Comprehensive Cancer Center will be for fall 2020, and the application deadline will be January 6, 2020.
Students who wish to apply after the January 6 deadline must contact the program director before submitting an application.